Home / Executive Moves / Chris Alexander Promoted to Parsons Govt Services Global Business Development Head

Chris Alexander Promoted to Parsons Govt Services Global Business Development Head

Chris Alexander
Chris Alexander

Christian “Chris” Alexander, a 10-year veteran of Parsons Corp. and a senior vice president, has been promoted to director of global business development for the company’s government services group.

The 25-year business development veteran will lead the group’s global sales and marketing program in his new role, Parsons said Thursday.

He succeeds Bill Bodie, who now heads business development for Fluor Corp.’s (NYSE: FLR) government group (click here to read our previous coverage of Bodie’s transition).

Alexander most recently served as SVP and business development manager for the group’s national security and defense division, where he pursued business in the homeland security, defense, intelligence and warfighter support markets.

Before joining the company, Alexander served as federal programs director for an engineering and construction contractor that performs environmental restoration work for the Naval Facilities Engineering Command.

He has o-authored health assessment documents for Environmental Protection Agency’s environmental criteria and assessment office, led remediation projects in Virginia and California and won military munitions response work at former defense sites in the U.S.

Alexander also helped carry out a program led by the Smithsonian Institution to develop a nutrient dynamics model of the Chesapeake Bay watershed for the National Science Foundation.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.